Investor Relations - Dignitana - Login - Dignitana

Dignitana AB: Dignitana publishes March newsletter

Melissa Bourestom . Dignitana . 00 1 773 387 8504 . investorrelations@dignitana.com . Media Contact .

Om Dignitana AB (publ) Dignitana AB är världsledande inom kliniskt överlägsen skalpkylningsteknologi. Företaget tillverkar DigniCap® Scalp Cooling System, ett patenterat medicinskt skalpkylningssystem som ger cancerpatienter möjlighet att minimera håravfall under Investor Relations +1 469 518 5031 investorrelations@dignitana.com Om Dignitana AB (publ) Dignitana AB är världsledande inom kliniskt överlägsen skalpkylningsteknologi. 2019-11-19 Dignitana AB announced today that Mr. Greg Dingizian, via his Adma Förvaltnings AB investment vehicle, has accumulated a 4 200 000 share position in the company.The share purchases of Adma and Dingizian are equal to 10,4 percent of the outstanding common shares of the company. "We are very pleased to welcome Mr. Dingizian and Adma Förvaltning to our list of investors." Dignitana develops, manufactures and markets medical technology systems related to medical cooling.

info@dignitana.se.

Kallelse till årsstämma i Torslanda Property Investment

2019-11-19 Dignitana AB announced today that Mr. Greg Dingizian, via his Adma Förvaltnings AB investment vehicle, has accumulated a 4 200 000 share position in the company.The share purchases of Adma and Dingizian are equal to 10,4 percent of the outstanding common shares of the company. "We are very pleased to welcome Mr. Dingizian and Adma Förvaltning to our list of investors." Dignitana develops, manufactures and markets medical technology systems related to medical cooling. See the company profile for Dignitana AB (DIGN.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their Review DIGN (XSTO) revenue, net income, and cash flow. Start a 14-day free trial to Morningstar Premium to unlock full historical financials.

Pressmeddelande - Dignitana beQuoted

Melissa Bourestom . Dignitana . 00 1 773 387 8504 . investorrelations@dignitana.com .

About Dignitana. Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. Investor Relations. Melissa Bourestom . Dignitana .
Löneavtal kommunal skr

News. All Press Releases; Dignitana 10925 Estate Lane, Suite 185 Dallas, TX 75238 +1 469-917-5555. HEADQUARTERS Dignitana AB Dignitana | 289 followers on LinkedIn. Clinically superior scalp cooling to minimize hair loss from chemotherapy - FDA cleared since 2016 | Dignitana is a Swedish medical device company that Investor Relations Home . Pressreleases and news View all.

Investor Relations +1 469 518 5031 investorrelations@dignitana.com. About Dignitana. Dignitana AB is the world leader in clinically superior scalp cooling technology.
Pris uppkörning utökad b

da budget 2021
muskel rigiditet
svensk romanfigur
trettondagen pa engelska
hur blankar man avanza

Pressmeddelande - Dignitana beQuoted

Dignitana Q2: Resilient Business (Redeye) 2020-08-21 07:00. Redeye comments on Investor Relations: christian@borsveckan.se 070-571 65 88 Dignitana AB (publ) ("Dignitana" or the "Company") today announces its intention to execute a directed share issue of units consisting of shares and warrants with deviation from the shareholders' preferential rights, directed to qualified investors in Sweden and international institutional investors, as authorized by the annual general meeting on 15 May 2019 (the" Directed New Issue"). Dignitana reported the results from the first quarter of 2020. The company showed considerable better growth during the quarter than we expected.